Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries

Gilead Sciences (GILD.O) said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries.